Quantcast

Latest biopharmaceutical Stories

2014-02-05 12:29:08

LA JOLLA, Calif., Feb. 5, 2014 /PRNewswire/ -- Avidity NanoMedicines LLC, a biopharmaceutical company pioneering a breakthrough approach to the targeted delivery of nucleic acid-based medicines, announced today that Arthur A. Levin, Ph.D., has joined the company as Executive Vice President of Research and Development. In this role, Dr. Levin will be responsible for leading Avidity's research and development organization and overseeing advancement of its drug pipeline. "Art brings an...

2014-02-05 08:28:25

CHESTERBROOK, Pa., Feb. 5, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the Leerink Swann Global Healthcare Conference to be held February 11-13, 2014 at the Waldorf Astoria Hotel in New York. Adrian Adams, Chief Executive Officer and President, is scheduled to participate in a discussion about the Company at 10:40...

2014-02-04 08:34:28

-Mr. Szekeres Brings Extensive Strategic and Transactional Deal Experience- LA JOLLA, Calif., Feb. 4, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the addition of David Szekeres to its executive management team as Chief Business Officer and General Counsel. Most recently, Mr. Szekeres served as Deputy General Counsel, Chief M&A Counsel...

2014-02-03 08:28:37

Healthcare Executive Brings Expertise in New Product Commercialization, Licensing, and Mergers and Acquisitions FORT COLLINS, Colo., Feb. 3, 2014 /PRNewswire/ -- CHD Bioscience, Inc. a development-stage biopharmaceutical company focused on the discovery, development and commercialization of novel products active against multi-resistant pathogens, is pleased to announce the appointment of Catherine Angell Sohn, Doctor of Pharmacy (Pharm.D.), to its Board of Directors. Dr. Sohn will...

2014-02-03 08:26:54

CHESTERBROOK, Pa., Feb. 3, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the BIO CEO & Investor Conference to be held February 10-11, 2014 at the Waldorf Astoria Hotel in New York. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product portfolio at 9...

2014-01-31 23:02:54

Recognizing the Outstanding People, Organizations and Technologies That Have Significantly Changed, Impacted, and Advanced the Efficiency of Biotherapeutic Development and Manufacturing; Awards Nominations Open Through June, 2014 New York, NY (PRWEB) January 31, 2014 BioProcess International (BPI), a business-to-business publication dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals, vaccines, cell therapies and therapeutics,...

2014-01-29 23:35:14

Gallus BioPharmaceuticals, a premier pure-play biologics contract manufacturing organization, has completed a second expansion of its Process Development facility at its headquarters in St. Louis, Missouri. This expansion provides additional laboratory space and state-of-the-art instrumentation to support Gallus’ growth and commitment to leading pharma and biotech clients in the development of new biotherapeutics. St. Louis, Missouri (PRWEB) January 29, 2014 Gallus BioPharmaceuticals,...

2014-01-29 08:31:10

Expansion Includes New State-of-the Art Fermentation Lab, Significantly Increased Floor Space and Additional Scientific Staff JUPITER, Fla., Jan. 29, 2014 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that the expansion of its research...

2014-01-28 08:30:47

DURHAM, N.C., Jan. 28, 2014 /PRNewswire/ -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis(TM) technology platform, today announced that the company will present a trial-in-progress update on the company's ongoing pivotal phase 3 clinical trial of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC). The...

2014-01-17 08:23:10

Marketing Approval Triggers Milestone Payment to Keryx NEW YORK, Jan. 17, 2014 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) today announced that its Japanese partner, Japan Tobacco Inc. (JT), has received manufacturing and marketing approval of ferric citrate from the Japanese Ministry of Health, Labour and Welfare. Ferric citrate, to be marketed in Japan by JT's subsidiary, Torii Pharmaceutical Co., Ltd., under the brand name Riona(®), is indicated as an oral...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related